You are here:
Publication details
Minor-clone TP53 mutations in CLL patients entering first-line treatment: clonal evolution and clinical impact.
Authors | |
---|---|
Year of publication | 2020 |
Type | Conference abstract |
MU Faculty or unit | |
Citation | |
Description | Aims • To assess the risk of clonal expansion of minor-clone TP53 mutations • To evaluate the clinical impact of TP53 mutations with different variant allele frequencies (VAFs) ...in patients entering first-line treatment |
Related projects: |
|